residual disease
Showing 1 - 7 of 7
Triple Negative Breast Cancer, Residual Disease Trial (Tetrathiomolybdate, Capecitabine, Pembrolizumab)
Not yet recruiting
- Triple Negative Breast Cancer
- Residual Disease
- Tetrathiomolybdate
- +2 more
- (no location specified)
Nov 15, 2023
Breast Cancer Female, Breast Cancer, Male, Breast Cancer Stage I Trial in United States (DC1 Vaccine, WOKVAC Vaccine)
Recruiting
- Breast Cancer Female
- +7 more
- DC1 Vaccine
- WOKVAC Vaccine
-
Tampa, Florida
- +6 more
Apr 4, 2022
Residual Disease Trial in Taipei (Cold snaring polypectomy/ Cold EMR/Hot EMR)
Recruiting
- Residual Disease
- Cold snaring polypectomy/ Cold EMR/Hot EMR
-
Taipei, Taiwan (roc), TaiwanNational Taiwan University Hospital
Nov 2, 2021
Triple Negative Breast Cancer, Residual Disease Trial in Boston (Niraparib, Radiation Therapy)
Recruiting
- Triple Negative Breast Cancer
- Residual Disease
- Niraparib
- Radiation Therapy
-
Boston, Massachusetts
- +1 more
Oct 27, 2021
Plasma Cell Myeloma, Residual Disease Trial in Chicago (Ixazomib Citrate, Lenalidomide, Dexamethasone)
Active, not recruiting
- Plasma Cell Myeloma
- Residual Disease
- Ixazomib Citrate
- +2 more
-
Chicago, IllinoisUniversity of Chicago
Oct 5, 2021
Residual Disease, Aggressive Periodontitis Trial in Sao Jose dos Campos (procedure, other, dietary supplement, drug)
Completed
- Residual Disease
- Aggressive Periodontitis
- Open flap debridement
- +3 more
-
Sao Jose dos Campos, SP, BrazilCollege of Dentistry - São José dos Campos, Sao Paulo State Univ
Nov 10, 2020
Colorectal Cancer, Residual Disease Trial in Tampere (blood draw)
Active, not recruiting
- Colorectal Cancer
- Residual Disease
- blood draw
-
Tampere, FinlandTampere University Hospital
Oct 26, 2020